Bausch Health Companies (BHC) Tax Provisions (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Tax Provisions came in at $88.0 million in Q2 2026, up 633.33% year-over-year from $12.0 million in Q2 2025, and up 14.29% quarter-over-quarter from $77.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Tax Provisions (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Tax Provisions across 18 years of filings, most recently posting $88.0 million for Q2 2026.
- In Q2 2026, Tax Provisions rose 633.33% year-over-year to $88.0 million; the TTM figure through Jun 2026 stood at $361.0 million (up 54.94% YoY), while the FY2025 annual figure was $247.0 million, up 3.35% from the prior year.
- Tax Provisions came in at $88.0 million for Q2 2026 at Bausch Health Companies, up from $77.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $159.0 million in Q4 2025 to a low of -$16.0 million in Q1 2022.
- Average Tax Provisions over 5 years is $53.1 million, with a median of $50.5 million recorded in 2023.
- Year-over-year, Tax Provisions tumbled 200.0% in 2022 and soared 633.33% in 2026.
- Over 5 years, Tax Provisions stood at $53.0 million in 2022, then declined by 24.53% to $40.0 million in 2023, then jumped by 177.5% to $111.0 million in 2024, then jumped by 43.24% to $159.0 million in 2025, then tumbled by 44.65% to $88.0 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $88.0 million in Q2 2026, $77.0 million in Q1 2026, and $159.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 121.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 54.80 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 12.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 1.38 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 88.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -59,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 12.40 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 8.20 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 42,000.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.00 Mn |
| Mar 31, 2026 | 77.00 Mn |
| Dec 31, 2025 | 159.00 Mn |
| Sep 30, 2025 | 37.00 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Mar 31, 2025 | 39.00 Mn |
| Dec 31, 2024 | 111.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | 49.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Sep 30, 2023 | 56.00 Mn |
| Jun 30, 2023 | 52.00 Mn |
| Mar 31, 2023 | 73.00 Mn |
| Dec 31, 2022 | 53.00 Mn |
| Sep 30, 2022 | 36.00 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Mar 31, 2022 | -16.00 Mn |
| Dec 31, 2021 | -51.00 Mn |
| Sep 30, 2021 | 25.00 Mn |